Streetwise Reports' Article Archives — June 2021 back to current month (26)

Coverage Initiated on Developer of Psychedelic Drugs for PTSD, Smoking Cessation (06/30/2021)

The investment thesis for Mydecine Innovations Group is presented in a ROTH Capital Partners report.


Diverse Pipeline for Repurposing Drug Company Includes Treatments for Idiopathic Pulmonary Fibrosis and Chronic Cough, Pancreatic Cancer and Stroke (06/30/2021)

Repurposing extends a drug's reach and value, and Algernon Pharmaceuticals' strategy of finding and demonstrating new uses for existing drugs reduces risk, accelerates time to market and increases capital efficiency.


Biotech Takes a 'Disruptive Drug Development Approach' to Destroy Dysregulated Transcription in Cancer (06/30/2021)

Kronos Bio's key assets are reviewed in an H.C. Wainwright & Co. report.


Cerevel Shares More Than Double on Positive Topline Results in Phase 1b Schizophrenia Trial (06/29/2021)

Shares of Cerevel Therapeutics hit a new 52-week high after the company released positive topline results for its CVL-231 in a Phase 1b clinical trial in schizophrenia patients.


Intellia Shares Rise 49% on 'Landmark' Interim Results in Phase 1 ATTR Amyloidosis Trial (06/28/2021)

Intellia Therapeutics soared to a new 52-week high after the firm reported that in a Phase 1 clinical study with partner Regeneron, it had achieved "landmark clinical data" that demonstrated deep reduction in disease-causing protein after a single infusion of NTLA-2001, an investigational CRISPR therapy for transthyretin (ATTR) amyloidosis.


Eli Lilly Receives FDA Breakthrough Therapy Designation for Alzheimer's Treatment (06/24/2021)

Eli Lilly and Co's shares traded 8% higher and reached a new 52-week high after the company reported the FDA granted its investigational antibody therapy donanemab Breakthrough Therapy designation for use in treating Alzheimer's disease.


Price Target Raised on Biopharma Achieving Positive Atopic Dermatitis Study Results (06/23/2021)

Aclaris Therapeutics' new clinical trial data and a recent financing are discussed in an H.C. Wainwright & Co. report.


Biotech Reports Encouraging Efficacy Data in Wet AMD, Target Price Raised 66% (06/23/2021)

These new results, from a Clearside Biomedical trial, are presented and interpreted in a ROTH Capital Partners report.


Analyst: Health Care Services/Tech Firm's 'Biggest Transaction Gets Even Bigger' (06/23/2021)

How the acquisition has grown and its effects on CloudMD Software & Services are addressed in a Research Capital Corp. report.


3D Systems and CollPlant Biotech to Create Bioprinted Breast Reconstruction Treatment Solutions (06/22/2021)

3D Systems Corp. shares rose 27% after the company reported it is partnering with CollPlant Biotechnologies to develop bioprinted solutions use to improve breast reconstruction treatments.


Anavex Posts Strong Correlated Biomarker Data in Phase 2 Adult Rett Syndrome Trial (06/21/2021)

Anavex Life Sciences shares traded 13% higher after the company reported that ANAVEX®2-73 (blarcamesine) biomarker correlated highly with the predetermined efficacy endpoints in its Phase 2 clinical trial of adult patients with Rett syndrome.


Entera Bio Granted Patent for Oral Parathyroid Hormone by EU Patent Authority (06/17/2021)

Entera Bio shares traded 25% higher after the firm received a foundational patent from the EU patent office for its oral parathyroid hormone using its platform oral protein delivery technology to treat osteoporosis and hypoparathyroidism.


Biotech Reports Positive Preclinical COVID-19 Study Results (06/16/2021)

These data and next steps for Novan's antiviral SB019 are provided in a ROTH Capital Partners report.


Immuno-oncology Firm Advances Lead Asset in Mesothelioma (06/16/2021)

The status of ONCOS-102 in several of Targovax's development programs is discussed in an H.C. Wainwright & Co. report.


Altimmune Posts Positive Interim Weight Loss Results in Phase 1 ALT-801 Trial (06/16/2021)

Altimmune Inc. shares traded 16% higher after the company reported positive interim data from a Phase 1 study of ALT-801 in overweight and obese trial participants.


Clearside Biomed Shares Rise 37% on Positive Data in Phase 1/2a Wet AMD Trial (06/15/2021)

Clearside Biomedical shares reached a new 52-week high after the company reported that the first cohort in its dose-escalating Oasis Trial of CLS-AX for treatment of neovascular age-related macular degeneration met all primary endpoints.


Enochian Bio's Shares Rise 54% After FDA Accepts Pre-IND Request for Potential HIV Cure (06/14/2021)

Shares of Enochian Biosciences Inc. traded higher after the company reported that the U.S. Food and Drug Administration accepted a pre-investigational new drug request for a potential functional cure or treatment for human immunodeficiency virus.


Sorrento's COVID Test Approved in Mexico (06/09/2021)

This and other recent developments involving Sorrento Therapeutics' pipeline and partners are covered in a Dawson James Securities report.


Tilray Shares Climb Higher on Roll Out of New Medical Cannabis Brand Symbios (06/09/2021)

Tilray Inc. shares traded 11% higher after the company reported the launch of a new medical cannabis brand, Symbios, designed to provide medicinal users with a broader spectrum of formats and cannabinoid potencies at improved price points.


Promising Psychedelic Drug Trials Show Potential for a New Biotech Boom (06/04/2021)

McAlinden Research Partners notes that continued advances in psychedelic therapies show potential to drive an investment boom that could reshape the future of medicine and mental health therapies.


Kindred Bio Shares Rise 29% after Achieving 100% Survival Rate in Canine Parvovirus Study (06/03/2021)

Kindred Biosciences Inc. shares reached a new 52-week high after the company reported its parvovirus monoclonal antibody, KIND-030, demonstrated highly positive results in preventing deaths in dogs infected by parvovirus.


Drug Repurposing Firm Launches Clinical Research Program in Pancreatic Cancer (06/03/2021)

Based on various positive preclinical and clinical studies, Algernon Pharmaceuticals is pursuing Ifenprodil as a potential treatment for pancreatic tumors.


Innovative Life Sciences Company Boosts Immune Function in Livestock Without the Use of Antibiotics (06/02/2021)

Avivagen's OxC-beta™ Livestock products could play a pivotal role in the global mandate to remove all in-feed antibiotics as growth promoters.


Biotech Receives National Cancer Institute Resources Award for Ovarian Cancer Vaccine Program (06/02/2021)

The award and other recent developments at Anixa Biosciences are covered in an H.C. Wainwright & Co. report.


Biotech Firm Confirms 100% Accuracy of COVID-19 Mutation Assays (06/02/2021)

Applied DNA Sciences' SARS-CoV-2 mutation panel and its validation are discussed in a ROTH Capital Partners report.


Constellation Pharma Shares Sparkle on $1.7 Billion Buyout Offer (06/02/2021)

Shares of Constellation Pharmaceuticals Inc. traded 65% higher after the company reported it entered into an agreement to be acquired by MorphoSys AG in an all-cash transaction for $34 per share.


More Archives

2024Jun May Apr Mar Feb Jan

2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports' Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes